Support First Things by turning your adblocker off or by making a  donation. Thanks!

Oh, that evil Big Pharma:  GlaxoSmithKlein has developed at great cost, over about two decades, a vaccination that can save many people—particularly children—from contracting malaria.  From the Guardian story:

Millions of children’s lives could be saved by a new vaccine shown to halve the risk of malaria in the first large-scale trials across seven African countries. The long-awaited results of the largest-ever malaria vaccine study, involving 15,460 babies and small children, show that it could massively reduce the impact of the much-feared killer disease. Malaria takes nearly 800,000 lives a year – mostly children under five. It damages many more. The vaccine has been in development for two decades – the brainchild of scientists at the UK drug company GlaxoSmithKline, which has promised to sell it at no more than a fraction over cost-price, with the excess being ploughed back into further tropical disease research.


Oh, and there is no doubt that animal research was involved in the creation of this vaccine, too. Double evil!

Comments are visible to subscribers only. Log in or subscribe to join the conversation.



Filter First Thoughts Posts

Related Articles